Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
BeiGene
National Cancer Institute (NCI)
Taproot Health
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
UNICANCER
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
National Cancer Institute (NCI)
Eisai Inc.
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Children's Oncology Group
CHA University
Radiation Therapy Oncology Group
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Radiation Therapy Oncology Group
Canadian Cancer Trials Group
Clinica Universidad de Navarra, Universidad de Navarra
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Northwestern University
University of California, San Francisco
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Abramson Cancer Center at Penn Medicine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
European Organisation for Research and Treatment of Cancer - EORTC
University of Washington
Alliance for Clinical Trials in Oncology
Northwestern University